We isolated CD45high and CD45low populations from patient-derived primary CRC cells (Figure 3A) and compared their relative sensitivity to 5-FU by determining the half-maximal inhibitory concentration (IC50) values based on reductions in cell viability to investigate the potential association between CD45 and intrinsic therapy resistance. Here, PTPRC is linked to colorectal carcinoma.